Additionally, 87% of members who began treatment with high blood pressure had normal blood pressure after 12 months
6 Importantly, these are life-saving therapies, independent of any impact they may have on the eye
Abstract Recent retrospective cohort studies showed that use of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) increased the incident risk of diabetic retinopathy and nonarteritic anterior ischemic optic neuropathy (NAION)
Systemic administrations of a cannabis hydroalcoholic extract, an endocannabinoid analog, or a CB 1 receptor agonist increased blood ghrelin concentrations in rats 83,84
58 GLP-1RAs potentially may reduce the risk of AF onset and progression through direct and indirect effects on atrial remodelling, including a reduction in systemic inflammation, improvement of cardiomyocyte metabolism, autonomic nervous system modulation, regulation of intracellular Ca 2+ levels and prevention and possibly reversion of atrial fibrosis
